LEADER 02242 am 22004453u 450 001 9910141570103321 005 20210602122325.0 010 $a3465132289 035 $a(CKB)2670000000360653 035 $a(EBL)1203857 035 $a(MiAaPQ)EBC1203857 035 $a(EXLCZ)992670000000360653 100 $a20050223d2004 uy 0 101 0 $ager 135 $aurmn#---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aVon der philosophisch-moralischen Erza?hlung zur modernen Novelle $e"Contes" und "nouvelles" von 1760 bis 1830 /$fKathrin Ackermann 210 1$aFrankfurt am Main :$cKlostermann,$dc2004. 215 $a1 online resource (398 pages) 225 1 $aAnalecta romanica,$x0569-986X ;$vHeft 70 300 $aDescription based upon print version of record. 311 08$a3465032284 320 $aIncludes bibliographical references (p. 367-389) and index. 330 $aHauptbeschreibung Die ersten Novellen, die Prosper Me?rime?e 1829 in der ""Revue de Paris"" vero?ffentlichte, galten in der Kritik schon fru?h als Geburt einer neuen Gattung, die einen klaren Buch mit den a?lteren ""contes"" und ""nouvelles"" vollzog. Die Literaturgeschichtsschreibung hat aus der umfangreichen Produktion auf dem Gebiet der ku?rzeren Erza?hlprosa des ausgehenden 18. und fru?hen 19. Jahrhunderts nur wenige Texte, vor allem die ""contes philosophiques"" der Aufkla?rer, kanonisiert, wa?hrend die große Masse jener ""contes"", ""nouvelles"", ""anecdotes"", ""histoires"" etc. dem Ve 410 0$aAnalecta romanica ;$vHeft 70. 606 $aShort stories, French$xHistory and criticism 606 $aFrench fiction$y18th century$xHistory and criticism 606 $aFrench fiction$y19th century$xHistory and criticism 608 $bElectronic books. 615 0$aShort stories, French$xHistory and criticism. 615 0$aFrench fiction$xHistory and criticism. 615 0$aFrench fiction$xHistory and criticism. 676 $a843/.0109 700 $aAckermann$b Kathrin$0913726 801 0$bMiAaPQ 912 $a9910141570103321 996 $aVon der philosophisch-moralischen Erza?hlung zur modernen Novelle$92047204 997 $aUNINA LEADER 05357nam 2200637Ia 450 001 9910143570303321 005 20170815114643.0 010 $a1-280-93510-3 010 $a9786610935109 010 $a0-470-11420-7 010 $a0-470-11419-3 035 $a(CKB)1000000000355502 035 $a(EBL)312187 035 $a(OCoLC)173621245 035 $a(SSID)ssj0000146714 035 $a(PQKBManifestationID)11137545 035 $a(PQKBTitleCode)TC0000146714 035 $a(PQKBWorkID)10186608 035 $a(PQKB)10456289 035 $a(MiAaPQ)EBC312187 035 $a(EXLCZ)991000000000355502 100 $a20060815d2007 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aEncyclopedia of infectious diseases$b[electronic resource] $emodern methodologies /$fedited by Michel Tibayrenc 210 $aHoboken, N.J. $cWiley-Liss$dc2007 215 $a1 online resource (807 p.) 300 $aDescription based upon print version of record. 311 $a0-471-65732-8 320 $aIncludes bibliographical references and index. 327 $aENCYCLOPEDIA OF INFECTIOUS DISEASES; Contents; Contributors; Biographical; Introduction: Infectious Diseases, the Major Challenge of Twenty-First Century Medicine; 1. Pulmonary Tuberculosis and Mycobacterium Tuberculosis: Modern Molecular Epidemiology and Perspectives; 1.1. Introduction; 1.2. General Points on Mycobacterium Tuberculosis (MTB) and Pulmonary Tuberculosis (PTB); 1.2.1. Classification and Cellular Characteristics; 1.2.2. Transmission and Multiplication of MTB; 1.2.3. Clinical and Subclinical TB; 1.2.4. Diagnosis of MTB Species; 1.2.5. Treatment, Drug Resistance, and Control 327 $a1.3. Genetics of MTB, Molecular Tools, and Population Structure1.3.1. Genome and Genetic Diversity of MTB; 1.3.2. Genetic Tools for Molecular Epidemiology; 1.3.3. How Should the Most Appropriate Molecular Marker be Chosen?; 1.3.4. Population Structure of MTB and Epidemiological Consequences; 1.4. Use of Molecular Epidemiology for Understanding Tuberculosis Transmission and Pathogenesis; 1.4.1. MTB Families and Worldwide Distribution; 1.4.2. MTB in Developing Versus Developed Countries; 1.4.3. Clinical and Epidemiological Relevance of Molecular Epidemiology at the Local Level 327 $a1.4.4. Use of Genotyping to Study the Impact of HIV/AIDS and Drug Resistance on Pathogenesis and Transmission1.5. Urgent Needs for TB Control, Limitations, and New Issues for Molecular Epidemiology; 1.5.1. Urgent Needs for TB Control and Molecular Epidemiology; 1.5.2. Limitations of Modern Molecular Tools; 1.5.3. Promising New Technologies; 1.6. Conclusion and Perspectives; Acknowledgments; Abbreviations; Glossary; References; 2. Diseases that Threaten Livestock; 2.1. Introduction; 2.2. Animal Diseases Under Control; 2.2.1. General Considerations; 2.2.2 Description of the Diseases 327 $a2.3. Diseases that Are an Economic Burden and Hamper International Trade in Animals and Animal Products2.3.1. General Considerations; 2.3.2. Description of the Diseases; 2.4. Animal Diseases that may Threaten Human Health; 2.4.1. Description of the Diseases; 2.5. Surveillance and Control of Transmissible Animal Diseases: Progress Expected from Modern Technologies; 2.6. Conclusion; References; 3. HIV/AIDS Infection in the World with a Special Focus on Africa; 3.1. Introduction; 3.2. Current State of the Epidemic; 3.2.1. Prevalences and Incidences in the World; 3.2.2. Mode of Transmission 327 $a3.2.3. Impact of HIV Infection on Other Endemic Diseases3.2.4. Demographic, Social, and Economic Consequences; 3.3. Molecular Epidemiology; 3.3.1. Classification of HIV; 3.3.2. Distribution of HIV-1 in Africa; 3.3.3. Implications of Recombination; 3.4. Implication of HIV Variability on Pathogenesis, Treatment, Diagnosis, and Vaccine Development in Africa; 3.4.1. Impact of HIV Variability on Diagnosis; 3.4.2. Impact of HIV Variability and Antiretroviral Therapy; 3.4.3. Impact of HIV Variability on Transmissibility and Pathogenesis; 3.4.4. Impact of HIV Variability on Vaccine Development 327 $a3.5. Access to Treatment 330 $aDiscover how the application of novel multidisciplinary, integrative approaches and technologies are dramatically changing our understanding of the pathogenesis of infectious diseases and their treatments. Each article presents the state of the science, with a strong emphasis on new and emerging medical applications. The Encyclopedia of Infectious Diseases is organized into five parts. The first part examines current threats such as AIDS, malaria, SARS, and influenza. The second part addresses the evolution of pathogens and the relationship between human genetic diversity and the spre 606 $aCommunicable diseases$vEncyclopedias 606 $aCommunicable diseases$xResearch$vEncyclopedias 608 $aElectronic books. 615 0$aCommunicable diseases 615 0$aCommunicable diseases$xResearch 676 $a362.196/9003 676 $a362.1969003 676 $a616.903 701 $aTibayrenc$b Michel$0889901 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910143570303321 996 $aEncyclopedia of infectious diseases$92296608 997 $aUNINA LEADER 01289nam 2200457 450 001 9910795693803321 005 20230803044119.0 010 $a88-921-5639-X 035 $a(CKB)5120000000186296 035 $a(MiAaPQ)EBC2071034 035 $a(Au-PeEL)EBL2071034 035 $a(CaPaEBR)ebr11066303 035 $a(OCoLC)911246547 035 $a(EXLCZ)995120000000186296 100 $a20150627h20132013 uy 0 101 0 $aita 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 12$aI regolamenti amministrativi /$fGiuseppe Greco 205 $aSeconda edizione. 210 1$aTurin, [Italy] :$cG. Giappichelli Editori,$d2013. 210 4$d©2013 215 $a1 online resource (382 pages) 311 $a88-348-8975-4 606 $aAdministrative law$zItaly 606 $aAdministrative courts$zItaly 606 $aAdministrative procedure$zItaly 615 0$aAdministrative law 615 0$aAdministrative courts 615 0$aAdministrative procedure 676 $a342.4506 700 $aGreco$b Giuseppe$039515 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910795693803321 996 $aRegolamenti amministrativi$9510893 997 $aUNINA